3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
243
Stomach Neoplasms
23
Breast Neoplasms, Male
16
Neoplasm Metastasis
14
Neoplasms
8
Inflammatory Breast Neoplasms
8
Esophageal Neoplasms
8
Brain Neoplasms
8
Colorectal Neoplasms
6
Adenocarcinoma Of Esophagus
4
Urologic Neoplasms
3
Triple Negative Breast Neoplasms
3
HER2-positive Breast Cancer
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Ductal, Breast
3
Gallbladder Neoplasms
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Lobular
2
Carcinoma, Intraductal, Noninfiltrating
2
Biliary Tract Neoplasms
2
Adenocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Solid Cancers
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Patient Preference
1
Patient Compliance
1
Interventions
pazopanib
4
tazemetostat
3
Doxorubicin
3
cixutumumab
2
Sorafenib
2
Radiotherapy
2
Radiation
2
Interferon-gamma
2
Ifosfamide
2
Gemcitabine
2
tremelimumab
1
temsirolimus
1
sapanisertib
1
romidepsin
1
pembrolizumab
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
interferon gamma-1b
1
indolepropanol phosphate
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sunitinib
1
Rifampin
1
Razoxane
1
Ramucirumab
1
Radiotherapy, Conformal
1
Observation
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Synovial
×
Trastuzumab
×
Clear all
No trials found.